Chimerix Correlations
| CMRX Stock | USD 0.94 0.01 1.08% |
The correlation of Chimerix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chimerix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chimerix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between Chimerix and NYA is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Chimerix and NYA in the same portfolio, assuming nothing else is changed.
Chimerix |
The ability to find closely correlated positions to Chimerix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chimerix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chimerix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chimerix to buy it.
Moving together with Chimerix Stock
| 0.78 | ENVB | Enveric Biosciences | PairCorr |
| 0.81 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.86 | SHC | Sotera Health | PairCorr |
| 0.67 | TIL | Instil Bio Earnings Call This Week | PairCorr |
Moving against Chimerix Stock
| 0.68 | BIAFW | BioAffinity Technologies | PairCorr |
| 0.55 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.42 | ELDN | Eledon Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Chimerix Stock performing well and Chimerix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Chimerix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TERN | 4.25 | 0.12 | 0.02 | 0.14 | 5.26 | 8.23 | 27.76 | |||
| AKRO | 2.66 | (0.53) | 0.00 | (0.29) | 0.00 | 4.94 | 20.22 | |||
| HEPA | 4.52 | (1.08) | 0.00 | 6.35 | 0.00 | 9.86 | 41.64 | |||
| DAWN | 3.20 | (0.34) | 0.00 | (0.25) | 0.00 | 6.30 | 21.23 |
Chimerix Corporate Management
| MD MBA | Chief Officer | Profile | |
| David CPA | Exec Officer | Profile | |
| Joshua Allen | Chief Imipridones | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Pablo MD | Head Affairs | Profile |
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.